Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Carfilzomib
Carfilzomib
FDA panel unanimously backs Onyx cancer drug
Yahoo/AP
Thu, 06/21/12 - 07:46 am
advisory panel
FDA
ONYX Pharmaceuticals
Carfilzomib
Multiple Myeloma
Onyx Pharma: FDA Panel Live Blog
TheStreet.com
Wed, 06/20/12 - 12:50 pm
ONYX Pharmaceuticals
FDA
advisory panels
Multiple Myeloma
Carfilzomib
4 Companies With Upcoming Drug Approval Dates With 1 Potential Buyout Looming
Seeking Alpha
Fri, 06/15/12 - 10:10 am
Onyx
Carfilzomib
Arena Pharmaceuticals
lorcaserin
Vivus
Qnexa
AMR101
Amarin
Obagi Medical Products
Outlooks for Pfizer, Arena and Onyx Following Busy May
TheStreet.com
Mon, 05/21/12 - 12:28 pm
Pfizer
Arena Pharmaceuticals
Onyx
lorcaserin
JAK3 inhibitors
Merck
Carfilzomib
Onyx Pharmaceuticals Announces FDA Advisory Committee to Review Carfilzomib for the Treatment of Patients with Relapsed and Refractory Multiple Myeloma
Pharmalive
Sat, 04/28/12 - 12:50 pm
ONYX Pharmaceuticals
Carfilzomib
Multiple Myeloma
Top 10 late-stage cancer drugs in 2012
Fierce Biotech
Wed, 04/18/12 - 12:11 pm
BB1608
Boston Biomedical
Dainippon Sumitomo
cabozantinib
Exelixis
ONYX Pharmaceuticals
Carfilzomib
Medivation
Astellas
Enzalutamide
Ariad Pharmaceuticals
Ponatinib
Bayer
regorafenib
Oncovex
Amgen
Roche
Genentech
T-DM1
Immunogen
Aveo
tivozanib
Zaltrap
Sanofi
Regeneron
FDA Irony: Less Data, Longer Review
Motley Fool
Mon, 12/12/11 - 10:47 pm
FDA
ONYX Pharmaceuticals
Carfilzomib
9 Biotech Companies With FDA Approval Decision Dates In Q1 2012
Seeking Alpha
Mon, 12/12/11 - 11:14 am
FDA
Fentanyl SL
INSYS Therapeutics
Dapagliflozin
Bristol-Myers Squibb
Prochieve
Columbia Laboratories
Discovery Labs
Surfaxin
NeurogesX
Qutenza
Curis
Roche
vismodegib
Chelsea Therapeutics
Northera
ONYX Pharmaceuticals
Carfilzomib
Onyx shares fall on likely delay in myeloma drug approval
Reuters
Mon, 12/12/11 - 11:04 am
ONYX Pharmaceuticals
myeloma
Carfilzomib
FDA
Onyx' Cancer Drug on Right Track
Yahoo/Zacks.com
Wed, 11/30/11 - 10:37 am
ONYX Pharmaceuticals
Carfilzomib
Multiple Myeloma
22 Hot Drugs Facing FDA Approval in 2012
TheStreet.com
Tue, 11/29/11 - 09:09 am
Amarin
AMR101
Ironwood
linaclotide
Merck
Ariad
ridaforolimus
Vivus
Qnexa
Avanafil
Amgen
Xgeva
Cell Therapeutics
pixantrone
Kalydeco
Vertex
ONYX Pharmaceuticals
Carfilzomib
Pfizer
Bristol-Myers Squibb
Eliquis
Chelsea Therapeutics
Northera
Levadex
MAP Pharmaceuticals
Roche
Curis
vismodegib
Biogen Idec
Elan
Tysabri
Amylin
Bydureon
Dapagliflozin
Uplypso
Protalix BioTherapeutics
Teva Pharmaceuticals
BioSante
Bio-T-Gel
Corlux
Corcept Therapeutics
Discovery Labs
Surfaxin
Onyx Pharmaceuticals Said to Weigh Sale as It Explores Strategic Options
Bloomberg
Tue, 11/29/11 - 08:24 am
ONYX Pharmaceuticals
Nexavar
M&A
Carfilzomib
5 One-Drug Wonders Going for No. 2
Motley Fool
Tue, 11/1/11 - 11:09 am
Dendreon
Provenge
DN24-02
Elan
Tysabri
bapineuzumab
ONYX Pharmaceuticals
Bayer
regorafenib
Carfilzomib
Nexavar
Vertex
Merck
Incivek
Kalydeco
Momenta
Lovenox
Copaxone
Teva Pharmaceuticals
Onyx Pharma submits NDA for carfilzomib in relapsed and refractory multiple myeloma
Pharmabiz
Sun, 10/2/11 - 12:35 pm
ONYX Pharmaceuticals
Carfilzomib
proteasome inhibitors
Multiple Myeloma
10 promising late-stage cancer drugs
Fierce Biotech
Tue, 04/5/11 - 10:47 pm
cancer
Carfilzomib
crizotinib
vismodegib
Oncovex
PLX4032
Ponatinib
SGN-35
tivozanib
T-DM1
cabozantinib
ONYX Pharmaceuticals
Pfizer
Genentech
Curis
Amgen
Plexxikon
Seattle Genetics
Ariad Pharmaceuticals
Aveo Pharmaceutical
Exelixis
Roche
Onyx multiple myeloma drug wins FDA fast-track status
Bizjournals.com
Tue, 02/1/11 - 08:20 am
ONYX Pharmaceuticals
Multiple Myeloma
FDA
fast track
Carfilzomib
Interesting Biotech Picks for 2011
Seeking Alpha
Sun, 01/16/11 - 11:31 am
biotech
Cerus
Array Biopharma
ONYX Pharmaceuticals
Carfilzomib
Impax Laboratories
Onyx jumps on new data for cancer drug carfilzomib
Yahoo/AP
Tue, 12/7/10 - 12:08 pm
ONYX Pharmaceuticals
Carfilzomib
Onyx Drug’s Mild Side Effects Let Myeloma Patients Stay on It
Bloomberg
Mon, 12/6/10 - 11:02 am
myeloma
ONYX Pharmaceuticals
Carfilzomib
Onyx Delays Cancer Drug Application As FDA Asks for More Data
Motley Fool
Fri, 10/8/10 - 08:12 am
ONYX Pharmaceuticals
FDA
Carfilzomib
Multiple Myeloma
Pages
1
2
next ›
last »